Bausch Health Cos (BHC) Competitors $6.04 -0.08 (-1.23%) Closing price 03:59 PM EasternExtended Trading$6.02 -0.01 (-0.17%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BHC vs. ABVX, RNA, CYTK, MRUS, RYTM, CRSP, GRFS, NUVL, AXSM, and LEGNShould you be buying Bausch Health Cos stock or one of its competitors? The main competitors of Bausch Health Cos include Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), Grifols (GRFS), Nuvalent (NUVL), Axsome Therapeutics (AXSM), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. Bausch Health Cos vs. Its Competitors Abivax Avidity Biosciences Cytokinetics Merus Rhythm Pharmaceuticals CRISPR Therapeutics Grifols Nuvalent Axsome Therapeutics Legend Biotech Abivax (NASDAQ:ABVX) and Bausch Health Cos (NYSE:BHC) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends. Do institutionals and insiders hold more shares of ABVX or BHC? 47.9% of Abivax shares are owned by institutional investors. Comparatively, 78.7% of Bausch Health Cos shares are owned by institutional investors. 20.0% of Bausch Health Cos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts prefer ABVX or BHC? Abivax currently has a consensus target price of $114.25, suggesting a potential upside of 19.50%. Bausch Health Cos has a consensus target price of $9.00, suggesting a potential upside of 49.13%. Given Bausch Health Cos' higher probable upside, analysts clearly believe Bausch Health Cos is more favorable than Abivax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abivax 1 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.91Bausch Health Cos 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to ABVX or BHC? In the previous week, Abivax had 14 more articles in the media than Bausch Health Cos. MarketBeat recorded 17 mentions for Abivax and 3 mentions for Bausch Health Cos. Abivax's average media sentiment score of 0.53 beat Bausch Health Cos' score of 0.25 indicating that Abivax is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abivax 3 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Bausch Health Cos 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation and earnings, ABVX or BHC? Bausch Health Cos has higher revenue and earnings than Abivax. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbivaxN/AN/A-$190.71MN/AN/ABausch Health Cos$9.63B0.23-$46M$0.2623.21 Which has more risk and volatility, ABVX or BHC? Abivax has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Bausch Health Cos has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Is ABVX or BHC more profitable? Bausch Health Cos has a net margin of 0.99% compared to Abivax's net margin of 0.00%. Abivax's return on equity of 0.00% beat Bausch Health Cos' return on equity.Company Net Margins Return on Equity Return on Assets AbivaxN/A N/A N/A Bausch Health Cos 0.99%-852.36%5.25% SummaryBausch Health Cos beats Abivax on 8 of the 14 factors compared between the two stocks. Get Bausch Health Cos News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CosMED IndustryMedical SectorNYSE ExchangeMarket Cap$2.27B$4.51B$6.11B$21.91BDividend YieldN/A0.88%5.73%3.62%P/E Ratio23.2110.6785.3630.12Price / Sales0.2323.77607.4466.99Price / Cash0.797.0737.4624.26Price / Book-6.784.4412.424.70Net Income-$46M-$134.23M$3.32B$1.01B7 Day Performance-5.11%1.24%1.01%-0.44%1 Month Performance-15.83%17.66%10.75%1.45%1 Year Performance-28.11%71.72%76.20%15.02% Bausch Health Cos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Cos4.4929 of 5 stars$6.04-1.2%$9.00+49.1%-25.7%$2.27B$9.63B23.2120,700ABVXAbivax2.8443 of 5 stars$95.63+2.0%$114.25+19.5%+925.4%$7.30BN/A0.0061Analyst ForecastRNAAvidity Biosciences1.9733 of 5 stars$48.96-1.6%$68.32+39.5%+3.0%$7.26B$10.90M-13.75190CYTKCytokinetics3.5724 of 5 stars$59.59-0.7%$76.64+28.6%+12.0%$7.18B$18.47M-11.68250MRUSMerus0.889 of 5 stars$94.85+0.5%$93.12-1.8%+81.8%$7.14B$36.13M-17.2537RYTMRhythm Pharmaceuticals3.0481 of 5 stars$100.770.0%$106.64+5.8%+109.4%$6.70B$130.13M-33.48140CRSPCRISPR Therapeutics1.5559 of 5 stars$68.29-6.5%$71.71+5.0%+45.1%$6.65B$37.31M-12.58460Analyst ForecastInsider TradeGRFSGrifols3.7632 of 5 stars$9.45+1.4%$10.30+9.0%+11.7%$6.41B$7.81B8.0823,822Positive NewsNUVLNuvalent2.9334 of 5 stars$89.75+1.9%$118.89+32.5%-18.0%$6.35BN/A-18.3240News CoverageAnalyst ForecastInsider TradeAXSMAxsome Therapeutics4.6921 of 5 stars$121.15-0.5%$177.93+46.9%+44.6%$6.07B$385.69M-23.90380Analyst RevisionLEGNLegend Biotech2.7934 of 5 stars$32.85+3.6%$69.25+110.8%-33.1%$5.85B$627.24M-37.332,609News CoverageHigh Trading Volume Related Companies and Tools Related Companies Abivax Alternatives Avidity Biosciences Alternatives Cytokinetics Alternatives Merus Alternatives Rhythm Pharmaceuticals Alternatives CRISPR Therapeutics Alternatives Grifols Alternatives Nuvalent Alternatives Axsome Therapeutics Alternatives Legend Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHC) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
